DOAC for improved patient outcomes in atrial fibrillation

A panel of eminent cardiologists and a neurologist discusses the role of DOAC in patients with atrial fibrillation (AF) at a Boehringer-Ingelheim sponsored symposium during the recent National Heart Association of Malaysia Congress 2024.